Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Purple Biotech (PPBT) Other Gross PP&E Adjustments (2019 - 2025)

Purple Biotech has reported Other Gross PP&E Adjustments over the past 4 years, most recently at -$467000.0 for Q4 2022.

  • Quarterly Other Gross PP&E Adjustments rose 24.56% to -$467000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$467000.0 through Dec 2022, up 24.56% year-over-year, with the annual reading at -$467000.0 for FY2022, 24.56% up from the prior year.
  • Other Gross PP&E Adjustments was -$467000.0 for Q4 2022 at Purple Biotech, up from -$505000.0 in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$108000.0 in Q2 2020 and troughed at -$790000.0 in Q4 2020.
  • The 4-year median for Other Gross PP&E Adjustments is -$562000.0 (2022), against an average of -$520666.7.
  • Year-over-year, Other Gross PP&E Adjustments soared 65.27% in 2020 and then tumbled 555.56% in 2021.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at -$206000.0 in 2019, then plummeted by 283.5% to -$790000.0 in 2020, then increased by 21.65% to -$619000.0 in 2021, then increased by 24.56% to -$467000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Other Gross PP&E Adjustments are -$467000.0 (Q4 2022), -$505000.0 (Q3 2022), and -$543000.0 (Q2 2022).